More than 1,500 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

The third scenario, in which the booster dose was with the Pfizer vaccine, showed the highest percentages of effectiveness: 56.8% against symptomatic infections and 85.5% against severe cases.

2 (Pfizer and Moderna) and JN.1 (Novavax ... what it means to be up to date on COVID-19 vaccination and updated vaccines (booster shots). Some of the criteria for the 2024-2025 updated vaccines ...

The booster shot – called mRNA-1273.211 ... be good to see data from studies of other variant vaccine boosters to compare to the Moderna combination. Expert advisors "must already be thinking ...

to two new-generation COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna, both targeting the new Omicron subvariants BA.4 and BA.5. The US regulator has cleared a 30 µg booster dose of a new ...

With pediatric COVID-19 cases reaching their highest peak in late January, according to data from the American Academy of Pediatrics, it’s absolutely crucial for young people to be as protected ...

A mass vaccination site in Tokyo’s Minato ... Inc. can be administered to people 12 and older, while Moderna Inc.’s Omicron booster is authorized for those 18 and older. In the past two ...